Information:
Fel:
ID
17546
Beskrivning
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.; ODM derived from: https://clinicaltrials.gov/show/NCT00107653
Länk
https://clinicaltrials.gov/show/NCT00107653
Nyckelord
Versioner (1)
- 2016-09-22 2016-09-22 -
Uppladdad den
22 september 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C, Chronic NCT00107653
Eligibility Hepatitis C, Chronic NCT00107653
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT00107653
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Adult | Age
Item
adult patients 18-65 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Chronic hepatitis C genotype 1
Item
chc, genotype 1
boolean
C4049392 (UMLS CUI [1])
Chronic Hepatitis C Evidence Serologic | Antibody test
Item
serologic evidence of chc infection by an antibody test
boolean
C0524910 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205473 (UMLS CUI [1,3])
C0580327 (UMLS CUI [2])
C3887511 (UMLS CUI [1,2])
C0205473 (UMLS CUI [1,3])
C0580327 (UMLS CUI [2])
Chronic liver disease Consistent with Hepatitis C, Chronic | Biopsy of liver
Item
chronic liver disease, consistent with chc infection on a liver biopsy obtained within the past 18 months
boolean
C0341439 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
C0193388 (UMLS CUI [2])
C0332290 (UMLS CUI [1,2])
C0524910 (UMLS CUI [1,3])
C0193388 (UMLS CUI [2])
Compensated liver disease
Item
compensated liver disease
boolean
C3839044 (UMLS CUI [1])
Contraceptive methods Quantity | Gender
Item
use of 2 forms of contraception during the study in both men and women
boolean
C0700589 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2])
interferon | Ribavirin
Item
previous interferon or ribavirin therapy
boolean
C0733470 (UMLS CUI [1])
C0035525 (UMLS CUI [2])
C0035525 (UMLS CUI [2])
Antiviral Therapy Systemic
Item
systemic antiviral therapy less than 24 weeks before first dose of study drug or expected need for this treatment any time during the study
boolean
C0280274 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205373 (UMLS CUI [1,2])
medical condition Associated with Chronic liver disease | Hemochromatosis | Hepatitis, Autoimmune | Alcoholic Liver Diseases | Exposure to toxin
Item
medical condition associated with chronic liver disease (eg, hemochromatosis, autoimmune hepatitis, alcoholic liver disease, toxin exposure)
boolean
C3843040 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0341439 (UMLS CUI [1,3])
C0018995 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
C0023896 (UMLS CUI [4])
C0040537 (UMLS CUI [5])
C0332281 (UMLS CUI [1,2])
C0341439 (UMLS CUI [1,3])
C0018995 (UMLS CUI [2])
C0241910 (UMLS CUI [3])
C0023896 (UMLS CUI [4])
C0040537 (UMLS CUI [5])
Decompensated liver disease
Item
decompensated liver disease
boolean
C4075847 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
women who are pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])